Free Trial

Cambridge Cognition (COG) Competitors

Cambridge Cognition logo
GBX 39 +1.50 (+4.00%)
As of 07:50 AM Eastern

COG vs. KOO, RENX, INHC, FDBK, TRLS, IQAI, DVRG, SENS, EMIS, and CRW

Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Kooth (KOO), Renalytix (RENX), Induction Healthcare Group (INHC), Feedback (FDBK), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.

Cambridge Cognition vs.

Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership, community ranking and profitability.

Kooth currently has a consensus target price of GBX 456.67, indicating a potential upside of 185.42%. Given Kooth's stronger consensus rating and higher probable upside, equities research analysts clearly believe Kooth is more favorable than Cambridge Cognition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cambridge Cognition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£50.72M1.16£4.00M£10.6415.03
Cambridge Cognition£15.64M1.04-£1.58M-£3.76-10.36

In the previous week, Cambridge Cognition's average media sentiment score of 0.10 beat Kooth's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Company Overall Sentiment
Kooth Neutral
Cambridge Cognition Neutral

Kooth has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500.

65.0% of Kooth shares are held by institutional investors. Comparatively, 35.2% of Cambridge Cognition shares are held by institutional investors. 17.3% of Kooth shares are held by insiders. Comparatively, 29.9% of Cambridge Cognition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cambridge Cognition received 91 more outperform votes than Kooth when rated by MarketBeat users. However, 93.33% of users gave Kooth an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

CompanyUnderperformOutperform
KoothOutperform Votes
14
93.33%
Underperform Votes
1
6.67%
Cambridge CognitionOutperform Votes
105
44.30%
Underperform Votes
132
55.70%

Kooth has a net margin of 7.89% compared to Cambridge Cognition's net margin of -10.07%. Kooth's return on equity of 18.59% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth7.89% 18.59% 10.12%
Cambridge Cognition -10.07%-68.83%-0.30%

Summary

Kooth beats Cambridge Cognition on 13 of the 17 factors compared between the two stocks.

Get Cambridge Cognition News Delivered to You Automatically

Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COG vs. The Competition

MetricCambridge CognitionHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£16.33M£212.61M£5.33B£2.62B
Dividend YieldN/A6.68%5.21%5.05%
P/E Ratio-10.36320.3826.71129.34
Price / Sales1.04433.24386.13221,585.85
Price / Cash4.3147.1438.2528.03
Price / Book5.375.376.773.79
Net Income-£1.58M-£15.55M£3.23B£5.88B
7 Day Performance2.63%1.11%1.80%0.62%
1 Month Performance7.14%8.16%11.10%22.12%
1 Year Performance-9.72%6.88%17.11%120.96%

Cambridge Cognition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COG
Cambridge Cognition
N/AGBX 39
+4.0%
N/A-14.2%£16.33M£15.64M-10.3680High Trading Volume
KOO
Kooth
N/AGBX 158
+10.9%
GBX 456.67
+189.0%
-48.0%£57.99M£50.72M14.84478Gap Up
RENX
Renalytix
N/AGBX 8
-5.9%
N/A-62.8%£33.16M£9.22M-0.38102
INHC
Induction Healthcare Group
N/AGBX 9.60
+1.1%
N/A-23.2%£8.86M£12.57M-1.7374
FDBK
Feedback
N/AGBX 13.55
-1.5%
N/A-80.6%£5.94M£3.88M-0.5524
TRLS
Trellus Health
N/AGBX 1.90
+2.7%
N/A+24.6%£3.67M£65,831.01-0.5531Gap Up
IQAI
IQ-AI
N/AGBX 0.85
+3.0%
N/A-39.3%£1.89M£538,190.00-13.676News Coverage
Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560News Coverage
CRW
Craneware
2.5875 of 5 stars
GBX 2,130
-3.6%
GBX 2,800
+31.5%
-2.7%£915.19M£230.77M78.70734

Related Companies and Tools


This page (LON:COG) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners